Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,472.3
-

 

  • STI Straits Times Index
    2,472.3
    -
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,509.1
    8.3 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,235.4
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,219.4
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,204.6
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,945.8
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,059.2M
  • Value: 869.3M
  • Rise: 172
  • Fall: 134
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.051+0.005
Sembcorp Marine0.142-0.002
Alset0.062-0.001
Samko Timber0.034+0.001
Avarga0.260+0.015
AnAn Intl0.033+0.004
Addvalue Tech0.024+0.001
Rex Intl0.146+0.003
Singtel2.140+0.020
ThaiBev0.585-

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ACCELERATE DIAGNOSTICS INC ACCELERATE DIAGNOSTICS
Updated on 25 Sep 2020 (End of trading day)
Last (USD): 11.500 Change: +1.100 High: 11.650 Remarks: -
Change (%): +10.58 Low: 10.370
Open 10.370 Yesterday's Close 10.4
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 365,294 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.49596 Trailing EPS (USD) e -1.46052 NAV (USD) b -0.6564
PE a - Trailing PE f - Price / NAV b -17.5198
Dividend (USD) d - Cash In Hand (USD) g 0.8405 Issued & Paid-up Shares c 56,355,300
Dividend Yield (%) d - Price / Cash In Hand g 13.682 Treasury Shares h -
Market Cap (M) 648.086 Enterprise Value (M) 703.465
Piotroski F Score 2 Exchange Code AXDX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 112.91 Free Float (%) 51.6
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 22 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ACCELERATE DIAGNOSTICS INC NASDAQ 648.086 - - -17.5198 -
Industry Medical Specialties NASDAQ 2,548.077 787.740 168.796 8.2542 0.035
Local Peer INTUITIVE SURGICAL INC NASDAQ 78,843.927 57.162 69.405 9.0205 -
Local Peer DEXCOM INC NASDAQ 38,522.832 381.037 188.192 28.4532 -
Local Peer IDEXX LABORATORIES INC NASDAQ 32,136.217 75.134 69.846 117.7297 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 25,048.656 56.572 14.723 8.8043 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 23,560.430 72.560 28.162 8.7487 -
Local Peer HOLOGIC INC NASDAQ 16,665.685 - 25.243 7.3902 -
Local Peer INSULET CORPORATION NASDAQ 14,703.086 1,267.531 809.998 26.1017 -
Local Peer MASIMO CORPORATION NASDAQ 12,412.776 63.261 55.855 9.2319 -
Local Peer ABIOMED INC NASDAQ 12,002.403 59.123 75.642 10.8930 -
Local Peer NOVOCURE LTD NASDAQ 10,806.628 - 916.049 40.3503 -
Local Peer DENTSPLY SIRONA INC NASDAQ 9,476.172 36.045 - 2.0409 0.876
Local Peer QUIDEL CORP NASDAQ 8,254.521 113.198 53.360 13.4942 -
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), BRUKER CORPORATION (NASDAQ), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), INARI MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), NUVASIVE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CAREDX INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INMODE LTD (NASDAQ), NANO-X IMAGING LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), SI BONE INC (NASDAQ), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), SURMODICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CUTERA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), IRADIMED CORP (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), MISONIX INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SIENTRA INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), DARIOHEALTH CORP (NASDAQ), INTRICOM CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), NEURONETICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CONFORMIS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPHROS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOVASC INC (NASDAQ), APPLIED UV INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), AVINGER INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), BIOLASE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), CELSION CORPORATION (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), CYANOTECH CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), DIGIRAD CORP (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CANCER GENETICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 183,161.329 49.962 59.603 5.9900 1.270
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 167,053.279 45.198 45.076 5.5917 0.181
Global Peer DANAHER CORP NYSE 146,961.168 59.049 50.310 4.4542 0.322
Global Peer MEDTRONIC PLC NYSE 138,669.735 28.956 31.430 2.7571 2.089
Global Peer STRYKER CORP NYSE 77,002.986 36.967 48.097 6.0376 1.038
Global Peer BECTON DICKINSON & CO NYSE 64,953.846 60.031 83.920 2.7042 1.282
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,421.218 11.366 13.422 3.4209 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,153.840 45.997 64.758 12.5429 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,070.269 31.443 36.861 3.3388 2.029
Global Peer BAXTER INTERNATIONAL INC NYSE 40,316.316 40.276 43.632 4.9602 1.067
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), TOPGLOV (Bursa), Top Glove (SGX), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), HARTA (Bursa), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), WATERS CORP (NYSE), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), PENUMBRA INC (NYSE), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), KANGJI MEDICAL (HKEx), AK MEDICAL (HKEx), EBOS GROUP (ASX), PEIJIA-B (HKEx), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), CIRC (HKEx), LIFETECH SCI (HKEx), KDL MEDICAL (HKEx), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), Medtecs Intl (SGX), MCP INCOME OPPORTUNITIES TRUST (ASX), YESTAR HEALTH (HKEx), UG Healthcare (SGX), GOLDEN MEDITECH (HKEx), CORMEDIX INC (NYSE American), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), RETRACTABLE TECHNOLOGIES INC (NYSE American), MODERN DENTAL (HKEx), ATOMO DIAGNOSTICS LIMITED (ASX), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), LKL (Bursa), VINCENT MED (HKEx), RESPIRI LTD (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), Biolidics (SGX), YUNNAN ENERGY (HKEx), SDI LTD (ASX), DAXOR CORP (NYSE American), RESAPP HEALTH LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), COMPUMEDICS (ASX), MICRO-X LTD (ASX), MILESTONE SCIENTIFIC INC (NYSE American), IMPEDIMED LIMITED (ASX), KELFRED (HKEx), OPTISCAN IMAGING (ASX), RESONANCE HEALTH LTD (ASX), ONCOCYTE CORP (NYSE American), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), INCANNEX HEALTHCARE LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), Yunnan Energy (SGX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), LIFE HEALTHCARE (HKEx), CARDIEX LTD (ASX), LBT INNOVATIONS LTD (ASX), OVENTUS MEDICAL LTD (ASX), METALICITY LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE), USCOM LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), ADHERIUM LIMITED (ASX), Annica (SGX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), STHAI (SET), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.280
+2.50 %
10 Days -+1.060
+10.15 %
20 Days --0.560
-4.64 %
Medium Term Return 3 Months --2.715
-19.10 %
6 Months -+3.500
+43.75 %
1 Year --7.420
-39.22 %
Long Term Return 2 Years --11.450
-49.89 %
3 Years --10.950
-48.78 %
5 Years --5.780
-33.45 %
Annualised Return Annualised --
-7.82 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.530 - 19.680 Change From 1 Year Low +6.970 % Change From 1 Year Low (%) +153.86
Change From 1 Year High -8.180 % Change From 1 Year High (%) -41.57
2 Years Range 4.530 - 24.000 Change From 2 Years Low +6.970 % Change From 2 Years Low (%) +153.86
Change From 2 Years High -12.500 % Change From 2 Years High (%) -52.08
5 Years Range 4.530 - 30.450 Change From 5 Years Low +6.970 % Change From 5 Years Low (%) +153.86
Change From 5 Years High -18.950 % Change From 5 Years High (%) -62.23
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 10.370 11.650 10.370 11.500 365,294 -
24 Sep 2020 10.680 10.680 10.210 10.400 146,509 -
23 Sep 2020 11.250 11.416 10.600 10.700 305,008 -
22 Sep 2020 11.300 11.390 10.960 11.150 116,807 -
21 Sep 2020 10.990 11.320 10.510 11.240 200,323 -
18 Sep 2020 11.260 11.330 10.795 11.220 439,294 -
17 Sep 2020 10.870 11.160 10.610 11.040 168,825 -
16 Sep 2020 11.160 11.355 10.840 11.100 193,220 -
15 Sep 2020 11.050 11.180 10.740 10.770 112,110 -
14 Sep 2020 10.440 11.160 10.440 10.980 172,454 -
11 Sep 2020 10.520 10.880 10.150 10.440 680,440 -
10 Sep 2020 9.920 10.810 9.600 10.440 758,275 -
09 Sep 2020 10.440 10.850 9.860 9.980 309,438 -
08 Sep 2020 11.000 11.260 10.360 10.370 326,923 -
04 Sep 2020 11.700 11.700 10.370 10.980 400,494 -
03 Sep 2020 12.200 12.380 11.710 11.710 571,175 -
02 Sep 2020 12.120 12.390 12.010 12.350 170,720 -
01 Sep 2020 12.060 12.310 12.005 12.140 193,926 -
31 Aug 2020 12.060 12.330 11.750 12.180 180,060 -
28 Aug 2020 12.160 12.290 11.840 12.060 172,493 -
27 Aug 2020 13.000 13.150 11.820 12.270 336,342 -
26 Aug 2020 13.300 13.558 12.990 13.030 285,497 -
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)
10.440 11.650 10.210 11.500 2,219,844 -
Previous 2 Weeks
(28 Aug 2020 to 11 Sep 2020)
12.160 12.290 10.210 10.440 3,763,944 -
4 Weeks from
(31 Jul 2020 to 27 Aug 2020)
15.060 15.395 10.210 12.270 7,507,817 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.